Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Glioblastoma 405Brain Neoplasms 163Glioma 159Gliosarcoma 131Astrocytoma 115Central Nervous System Neoplasms 110Melanoma 75Oligodendroglioma 74Neuroblastoma 44Neoplasms 33Medulloblastoma 33Neoplasm Metastasis 29Recurrence 28Ependymoma 26Sarcoma 23Sarcoma, Ewing 22Rhabdomyosarcoma 18Small Cell Lung Carcinoma 16Lymphoma 16Carcinoma, Non-Small-Cell Lung 16Diffuse Intrinsic Pontine Glioma 15Lung Neoplasms 14Breast Neoplasms 14Ovarian Neoplasms 13Neuroendocrine Tumors 13Choroid Plexus Neoplasms 13Optic Nerve Glioma 11Neuroectodermal Tumors, Primitive 11Spinal Cord Neoplasms 10Rhabdoid Tumor 10

Interventions

Cytarabine 82Etoposide 32Daunorubicin 31Idarubicin 26Filgrastim 26Mitoxantrone 22Busulfan 18Peripheral Blood Stem Cell Transplantation 17fludarabine phosphate 14Gemtuzumab 14Cyclophosphamide 14tipifarnib 11Clofarabine 10Azacitidine 10Radiotherapy 9Methotrexate 9Gene Expression Profiling 9sargramostim 8Flow Cytometry 8Granulocyte Colony-Stimulating Factor 7Decitabine 7Cyclosporine 7alvocidib 6Topotecan 6Tacrolimus 6Bortezomib 6Antilymphocyte Serum 6valspodar 5aldesleukin 5Vorinostat 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myelomonocytic, Acute × Temozolomide × Clear all
NCT01139970 2025-11-20

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
66 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡